Prescription RequiredNuparp contains Rucaparib 300mg, a PARP (poly ADP-ribose polymerase) inhibitor used in the treatment of certain types of cancer, including advanced ovarian and prostate cancers associated with BRCA mutations.
| Generic Name | Rucaparib |
| Manufacturer | Zydus Cadila |
| Packing | 60 Tablets in a Bottle |
| Prescribed For | Prostate Cancer |
| Availability | In Stock |
As a fully licensed supplier of high-quality anticancer medicines, we provide Nuparp (Rucaparib 300 mg Tablets), widely used for the treatment of advanced ovarian and prostate cancer.
We ensure safe, consistent, and timely bulk supply of generic oncology drugs to hospitals, clinics, pharmacies, healthcare providers, physicians, NGOs, and authorized buyers in over 80 countries worldwide. Our distribution network spans Latin America, Africa, Asia, Europe, the Middle East, and North America, covering regions such as Mexico, Brazil, Colombia, Peru, Chile, UAE, Saudi Arabia, Egypt, South Africa, Namibia, Kenya, Nigeria, Singapore, Vietnam, Thailand, the Philippines, Canada, and many more.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.
